Integrated Wealth Concepts Boosts AbbVie Holdings

Investment firm increases stake in pharmaceutical company by 8.4% in Q3

Mar. 17, 2026 at 9:35am

Got story updates? Submit your updates here. ›

Integrated Wealth Concepts LLC, an investment management firm, has increased its stake in AbbVie Inc. (NYSE:ABBV) by 8.4% during the third quarter, according to a recent disclosure with the Securities and Exchange Commission (SEC). The firm now owns 60,063 shares of the pharmaceutical company's stock, valued at $13.9 million.

Why it matters

AbbVie is a major pharmaceutical company known for its blockbuster drugs like Humira. Institutional investors closely watch changes in ownership of large-cap healthcare stocks like AbbVie, as it can signal broader market trends and investor sentiment.

The details

Integrated Wealth Concepts added 4,643 shares of AbbVie to its portfolio during the third quarter. The firm now holds a total of 60,063 shares, representing an 8.4% increase in its position. AbbVie's stock has seen volatility in recent months as the company faces patent expirations and competition for some of its key products.

  • Integrated Wealth Concepts disclosed the increased stake in AbbVie in a filing with the SEC on March 17, 2026.
  • The firm added the additional 4,643 shares during the third quarter of 2025.

The players

Integrated Wealth Concepts LLC

An investment management firm that oversees a portfolio of equity and fixed-income investments for its clients.

AbbVie Inc.

A global biopharmaceutical company that develops and markets a variety of specialty medicines, including the blockbuster drug Humira.

Got photos? Submit your photos here. ›

The takeaway

Institutional investors like Integrated Wealth Concepts are closely monitoring the performance and outlook for major pharmaceutical companies like AbbVie as they navigate patent expirations and competitive pressures. Changes in ownership stakes can provide insights into broader market trends and investor sentiment around the healthcare sector.